Endoscopic Classification of Fundoplication Integrity Predicts Pathologic Reflux
ENDOSCOPIC CLASSIFICATION OF FUNDOPLICATION INTEGRITY PREDICTS PATHOLOGIC REFLUX: DEVELOPMENT AND PROSPECTIVE VALIDATION
1 other identifier
observational
153
1 country
1
Brief Summary
This single-center, two-phase cohort study aimed to develop and validate a simple endoscopic classification of fundoplication integrity after anti-reflux surgery (ARS - Nissen or Toupet fundoplication). Consecutive adult patients undergoing endoscopy, high-resolution manometry (HRM), and reflux monitoring after ARS were included. Retroflexed endoscopic videoclips were reviewed blinded to clinical and functional results. In the development cohort (2018-2024, n=73), individual endoscopic parameters were tested against pathologic GERD (Lyon 2.0 criteria). Three parameters significantly correlated with pathologic reflux: (1) intrathoracic valve location, (2) disrupted valve (deep anterior and/or posterior grooves), and (3) visible hiatal opening. Patients were stratified according to the number of impaired mechanisms (0-3). Symptom burden, manometric abnormalities, and reflux metrics worsened progressively with increasing impairment. The rate of pathologic GERD rose from 11.8% (0 mechanisms) to 37.5% (1-2 mechanisms) to 85.7% (3 mechanisms). The classification was then prospectively validated in an independent cohort (2024-2026, n=49), reproducing the same stepwise correlation. The number of impaired mechanisms showed excellent discriminatory capacity for pathologic GERD (AUC 0.860 in development, 0.870 in validation; overall AUC 0.869). This simple endoscopic classification, based on only three objective parameters, reliably identifies fundoplication failure and correlates with symptoms and objective pathophysiologic data. It has the potential to standardize endoscopic reporting after ARS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
CompletedFirst Submitted
Initial submission to the registry
July 19, 2026
CompletedFirst Posted
Study publicly available on registry
July 23, 2026
CompletedJuly 27, 2026
July 1, 2026
8 years
July 19, 2026
July 24, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
acid exposure time
time of pH\<4 during the pH monitoring test
during pH impedance monitoring
Study Arms (3)
Normal fundoplication
Patients with 0 impaired mechanisms of ARB restoration
Partially impaired fundoplication
Patients with 1-2 impaired mechanisms of ARB restoration
Fully impaired fundoplication
Patients with 3 impaired mechanisms of ARB restoration
Eligibility Criteria
Patients who underwent anti-reflux surgery and a complete manometric, reflux monitoring and endoscopic assessment
You may qualify if:
- Adults (18-90 years)
- Previous Nissen or Toupet fundoplication for GERD or large hiatal hernia
- Completion of post-operative esophagogastroduodenoscopy (EGD)
- Adequate retroflexed endoscopic videoclip
- Post-operative High-resolution manometry (HRM) and reflux monitoring (MII-pH or wireless pH)
You may not qualify if:
- Other foregut operations (Dor, Collis, magnetic sphincter augmentation, bariatric surgery)
- Insufficient quality of endoscopic videoclips
- Missing HRM or reflux monitoring
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IRCCS Policlinico San Donato
San Donato Milanese, Milan, 20097, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Weeks
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MEDICAL DOCTOR
Study Record Dates
First Submitted
July 19, 2026
First Posted
July 23, 2026
Study Start
April 1, 2018
Primary Completion
April 1, 2026
Study Completion
July 1, 2026
Last Updated
July 27, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share